<head>
    <!-- Stylesheet -->
    <link rel="stylesheet" href="css/efficacy.css">
</head>
<!-- Main -->
<main>
    <div class="tabs">
        <a href="" ui-sref="ORR" class="tab">ORR</a>
        <a href="" ui-sref="TUMOR-VOLUME-ASSESSMENT" class="tab tab--active">TUMOR VOLUME ASSESSMENT</a>
        <a href="" ui-sref="DOR" class="tab">DoR</a>
    </div>
    <h2 class="primary">Post-treatment Individual Tumor Volume Assessment<sup>2</sup></h2>

    <img src="assets/svg/efficacy-graphic.svg" alt="Although the exact mechanism of action (MOA) of HDAC inhibitors is still being studied, BELEODAQ is believed to work as follows" />

    <div class="treatment-assessments">
    <h3 class="secondary-variant">Individual tumor response was assessed in 93 patients (77.5%) with post-treatment assessments<sup>*</sup></h3>

    <ul>
        <li>
            <p>63.3% (n = 59/93) had a decrease in tumor volume</p>
        </li>
        <li>
            <p>36.6% (n = 34/93) patients had an increase in tumor volume</p>
        </li>
    </ul>
    <p class="light">Assessments were based on the difference in the sum of the products of greatest diameters between baseline and post-treatment assessments. No statistical inferences can be drawn from these results
    </p>
</div>
    <p class="semibold"><sup>*</sup>93 of the 120 patients had measurable disease at both baseline and post-treatment assessment.</p>
    <div class="button-group">
        <a href="" ui-sref="INCLUSION-CRITERIA" class="button secondary"><i class="fas fa-chevron-left"></i>BELIEF Trial</a>
        <a href="" ui-sref="SAFETY" class="button">Safety &amp; Tolerability <i class="fas fa-chevron-right"></i></a>
    </div>
</main>